CROs/Service Providers

Recipharm acquires Flamel Technologies facility in France

Monday, December 1, 2014 12:57 PM

Recipharm, a contract development and manufacturing organization based in Sweden, will purchase Flamel Technologies’ development and manufacturing facility in Pessac, France. Recipharm also will provide development and manufacturing support to Flamel under a long-term services agreement.

More... »


Grünenthal terminates license agreement with Actavis for cebranopadol

Monday, December 1, 2014 12:56 PM

Grünenthal, an independent, family-owned, international, research-based pharmaceutical company headquartered in Aachen, Germany, has terminated a license agreement with Actavis for the development and commercialization of cebranopadol, a novel analgesic for the treatment of chronic pain.

More... »


MESA Group acquires Spintech in Turkey

Monday, December 1, 2014 12:54 PM

Swiss-based MESA Group Holdings, a pan-European, independent, multi-vendor services provider, has acquired Spintech, a Turkish service provider for multi-vendor diagnostic imaging equipment, asset management and maintenance services.

More... »

Accovion launches new subsidiary in France

Monday, December 1, 2014 12:52 PM

Accovion, an independent, European, full-service CRO headquartered in Frankfurt, Germany, has established a new subsidiary in Lyon, France, as it continues its expansion across Europe. Together with offices in Italy, Poland, Russia, Romania, Spain, Czech Republic and the U.K., Accovion now is able to present itself with eight subsidiaries and overall coverage of 20 European countries.

More... »

WuXi AppTec launches enhanced genomics services for Chinese researchers

Monday, December 1, 2014 12:39 PM

WuXi PharmaTech, an open-access R&D capability and technology platform company serving the pharma, biotech and medical device industries with operations in China and the U.S., has announced an enhancement to its genomics services. The WuXi Genome Center will provide Chinese researchers who use its gene sequencing services with access to the integrated sequence analysis capabilities of NextCODE Health, a bioinformatics company based in Cambridge, Mass.

More... »

Almac, ESMS Global collaborate

Monday, November 24, 2014 02:45 PM

Almac, a global provider of advanced clinical technology and support services, and ESMS, a 24/7 medical emergency response service for clinical trials based in the U.K., are collaborating to offer clients an exclusive solution surrounding emergency unblinding procedures.

More... »

NextDocs joins the Parexel Perceptive Partner Program

Monday, November 24, 2014 02:41 PM

NextDocs, a Conshohocken, Pa.-based provider of regulated content management and compliance solutions for the life sciences industry, has joined the Parexel Perceptive Partner Program. NextDocs will enhance and broaden its services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform, a suite of applications for managing clinical trials. 

More... »

Altasciences expands to U.S., launches Algorithme Pharma USA

Thursday, November 20, 2014 01:36 PM

Altasciences has opened Algorithme Pharma USA, further expanding the company’s North American footprint and ability to provide comprehensive bioequivalence and phase I/IIa clinical drug development capabilities in the U.S.

More... »

Recipharm acquires Lusomedicamenta

Friday, November 14, 2014 02:21 PM

Recipharm, a Swedish pharmaceutical contract development and manufacturing organization (CDMO), has acquired Lisbon, Portugal-based CDMO Lusomedicamenta Sociedade Técnica Farmacêutica.

More... »

Catalent acquires Micron Technologies

Friday, November 14, 2014 02:19 PM

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired Micron Technologies, a Boise, Idaho-based global provider of particle size engineering technologies.

More... »

Subscribe to The CenterWatch Monthly
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs